Vijaypd Ceutical IPO Allotment Status to be Finalized Today: Check via NSE and Registrar

Mumbai, October 3, 2025: The allotment for Vijaypd Ceutical Ltd’s IPO ₹19.25 crore SME IPO is expected to be finalised today. The issue, which ran from 29 September to 1 October, received bids for 74.48 lakh shares against 55 lakh shares on offer, resulting in a total subscription of 1.35 times. Share credits and refunds are scheduled for 6 October 2025, ahead of the company’s listing on the NSE Emerge platform on 7 October 2025.

How to Check Vijaypd Ceutical IPO Allotment Status on NSE

• Visit the official NSE allotment portal: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• Select Vijaypd Ceutical Ltd from the list of IPOs.
• Type PAN, application number, or DP/Client ID.
• Enter the captcha code and continue.
• The allotment status will be displayed.

How to Check Vijaypd Ceutical IPO Allotment Status via Registrar (Kfin Technologies)

• Visit the Kfintech IPO status page: https://ipostatus.kfintech.com/
• Choose Vijaypd Ceutical Ltd from the IPO drop-down.
• Include your PAN, DP/Client ID, or application number.
• Press ‘Submit’ to check for allotment of shares.

Vijaypd Ceutical IPO Schedule

Allotment basis of the Vijaypd Ceutical IPO will be completed on October 3, 2025. Refunds and credits of the shares into the demat accounts of the investors will be made on October 6, 2025. The company’s listing on the stock exchange is scheduled to take place on October 7, 2025.

Investors will be able to view their status by this evening on the NSE or Kfintech platform after the allotment is uploaded.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations